We previously described a multiplexed in vitro genotoxicity assay based on flow cytometric analysis of detergent-liberated nuclei that are simultaneously stained with propidium iodide and labeled with fluorescent antibodies against p53, gH2AX, and phospho-histone H3. Inclusion of a known number of microspheres provides absolute nuclei counts. The work described herein was undertaken to evaluate the interlaboratory transferability of this assay, commercially known as MultiFlow V R DNA Damage Kitp53, gH2AX, Phospho-Histone H3. For these experiments, seven laboratories studied reference chemicals from a group of 84 representing clastogens, aneugens, and nongenotoxicants. TK6 cells were exposed to chemicals in 96-well plates over a range of concentrations for 24 hr. At 4 and 24 hr, cell aliquots were added to the MultiFlow reagent mix and following a brief incubation period flow cytometric analysis occurred, in most cases directly from a 96-well plate via a robotic walk-away data acquisition system. Multiplexed response data were evaluated using two analysis approaches, one based on global evaluation factors (i.e., cutoff values derived from all interlaboratory data), and a second based on multinomial logistic regression that considers multiple biomarkers simultaneously. Both data analysis strategies were devised to categorize chemicals as predominately exhibiting a clastogenic, aneugenic, or nongenotoxic mode of action (MoA). Based on the aggregate 231 experiments that were performed, assay sensitivity, specificity, and concordance in relation to a priori MoA grouping were 92%. These results are encouraging as they suggest that two distinct data analysis strategies can rapidly and reliably predict new chemicals' predominant genotoxic MoA based on data from an efficient and transferable multiplexed in vitro assay. Environ. Mol. Mutagen. 58:146-161, 2017. 
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INTRODUCTION
Genotoxicity assessment has historically involved the application of several assays, each of which is sensitive to different type(s) of DNA damage [Dearfield et al., 1991] . This is related to the fact that no single assay can reliably detect all three key types of DNA damage-gene mutation, structural chromosomal damage, and aneuploidy [Cimino, 2006] . In regard to in vitro systems, the reverse mutation assay in Salmonella bacteria, and micronucleus and chromosomal aberration assays in mammalian cells are common examples [Ames et al., 1973; Galloway Additional Supporting Information may be found in the online version of this article. Grant sponsor: National Institute of Health/National Institute of Environmental Health Sciences (NIEHS); Grant number: R44ES024039. et al., 1994; Corvi et al., 2008] . Results from multiple in vitro and in vivo assays are used to form an understanding about a chemical's intrinsic genotoxic potential, and furthermore results from several assays can be indicative of a predominant genotoxic mode of action (MoA; meaning primarily arising from clastogenic or aneugenic activity for the purposes of this report). However, in practice reaching firm conclusions regarding MoA is often challenging. For one, the in vitro tests in mammalian cells have been described as being prone to giving genotoxic responses that are secondary to cellular stress such as high levels of cytotoxicity or damage to certain non-DNA targets [Kirkland et al., 2007] . Second, the conventional tests within the batteries are usually performed with different indicator organisms, treatment schedules, and test chemical concentrations. Finally, resources and test chemical requirements are relatively high for the series of single endpoint assays.
In the future, especially in regard to early stages of safety assessments, it would be advantageous to use assay(s) that provide higher throughput, require lower amounts of test chemical, and evaluate multiple biomarkers/parameters in parallel that can provide insights into MoA. These goals explain recent efforts to develop higher information content genotoxicity assays that are amenable to rapid, automatic data acquisition platforms. Diverse approaches have been investigated, and include automation of conventional genotoxicity endpoints [Avlasevich et al., 2006; Rossnerova et al., 2011] , identification of toxicogenomic signatures [Li et al., 2015] , use of stably transfected cells with reporters for GADD45a, p53, or other DNA damage signaling pathways [Yang and Duerksen-Hughes, 1998; Hendriks et al., 2012; Walmsley and Tate, 2012] , and use of various phenotype-based biomarkers of genotoxicity, for example induction of hypo-/ hyperdiploidy in mitotic cells [Muehlbauer and Schuler, 2005; Muehlbauer et al., 2008] , or gH2AX [Audebert et al., 2010; Smart et al., 2011; Garcia-Canton et al., 2013; Nikolova et al., 2014; Cheung et al., 2015] .
One line of investigation that has been pursued by our laboratories is the development of a multiplexed flow cytometric assay that combines several biomarkers relevant to DNA damage response pathways Bryce et al., 2016] . This method involves a onestep, add-and-read process that efficiently prepares samples in microtiter plate-format for high throughput analysis via flow cytometry. The biomarker responses studied include phosphorylation of histone H3 (p-H3) and histone H2AX (gH2AX) to identify mitotic cells and DNA double strand break repair foci, respectively; nuclear p53 content to measure DNA damage response; frequency of 8n cells as an indicator of polyploidization; and determination of absolute nuclei counts, which conveys information about treatment-related cytotoxicity. As initially described the multiplexed assay was accompanied by logistic regression analyses that provided probability scores for grouping by MoA: clastogen, aneugen, or nongenotoxicant. We recognize that some chemicals may possess both clastogenic and aneugenic properties, but we considered a systematic investigation of such mixed activities beyond the scope of the present investigation. Thus, the work described herein more simply sought to evaluate the MutliFlow assay's ability to make an attribution about predominant genotoxic MoA. Given the high throughput and dimensionality of the assay, our present report also explores multiple approaches for efficiently analyzing and interpreting the collection of biomarker responses that are generated.
To assess the assay's performance across laboratories, this work involved seven laboratories that treated cells with chemicals chosen from a set of 84. The type of cells (human TK6) and other key experimental design considerations were kept constant. Beyond evaluating transferability aspects of the bioassay itself, the robustness of two data analysis strategies was evaluated. The results are discussed in terms of interlaboratory performance, and recommendations are made regarding approaches for working with multiplexed data of this nature.
MATERIALS AND METHODS

Chemicals
The identity of the 84 selected test chemicals are provided in Table I . Our a priori categorization of genotoxic MoA is also provided. Aneugens (13) and clastogens (33) were selected from the literature and represent a broad range of genotoxic mechanisms that have generally been evaluated in multiple laboratories and in both in vitro as well as in vivo systems. The nongenotoxicants (38) were selected for their diverse range of toxic mechanisms, and many are part of an ECVAM list of agents that are considered to be negative in in vitro genotoxicity testing [Kirkland et al., 2008 . Collaborators chose a number of aneugens, clastogens, and nongenotoxicants from the list, influenced by considerations that included availability, project resources, and their interest in particular chemical spaces.
Cell Culture and Treatments
Litron, Bayer, Sanofi, and Pfizer purchased TK6 cells from ATCCV R (cat. no. CRL-8015). Servier, Roche, and Orion obtained TK6 cells from ECACC (cat. no. 13051501). Cells were grown in a humidified atmosphere at 378C with 5% CO 2 . For routine culturing, the cells were maintained at or below 1 3 10 6 cells/mL. The culture medium consisted of RPMI 1640 with 200 mg/mL sodium pyruvate, 200 mM L-glutamine, 50 units/mL penicillin, 50 mg/mL streptomycin, and 10% v/v heatinactivated horse serum. Note that minor variations to culture medium were utilized by several laboratories as follows: Pfizer did not supplement with additional L-glutamine; Sanofi used Glutamax instead of Lglutamine; Bayer used 10% v/v heat-inactivated fetal bovine serum, and 1% penicillin-streptomycin solution (Sigma-Aldrich, cat. no. P4333); Sanofi did not include antibiotics; Roche included kanamycin in their growth medium.
On the day of treatment, logarithmically growing cells were exposed to 20 concentrations of test chemical. Each concentration was evaluated in a single well except for solvent controls that were evaluated in four Environmental and Molecular Mutagenesis. DOI 10.1002/em Kirkland et al., 2008 Environmental and Molecular Mutagenesis. DOI 10.1002/em replicate wells. The solvent was DMSO except in several instances noted in Table I . In all cases, the final solvent concentration was 1% v/v in culture. Soluble nontoxic chemicals were tested up to 1000 mM. In some cases, solubility influenced top concentration, and in these instances, it was the highest nonprecipitating concentration that was studied. In other cases, Litron's prior experience with these chemicals suggested lower top concentrations would be appropriate, for example in the case of highly cytotoxic compounds. Regardless of top starting concentration, each successively lower concentration differed by a factor of square root 2, for example, 1000, 707, 500, 354, 250 mM, etc. Note that Orion concentration spacing was slightly different-1000, 750, 500, 375, 250 mM, etc. Treatment of cells took place after they were adjusted to 2 3 10 5 cells/mL and 198 mL of this cell suspension was added to each well of round-bottom 96-well plates. Addition of test chemical (2 mL/well) was immediately followed by re-incubation of the cells in a humidified atmosphere at 378C with 5% CO 2 .
DNA Damage Assay
At each sampling time nuclei were prepared for cytometric analysis using reagents and instructions included in prototype MultiFlow V R DNA Damage Kit-p53, gH2AX, Phospho-Histone H3 (Litron Laboratories, Rochester, NY). The proprietary working solution was used to simultaneously digest cytoplasmic membranes, stain chromatin with a fluorescent nucleic acid dye, and label several nuclear epitopes with fluorescent antibodies. Specifically, anti-gH2AX-Alexa FluorV R 647 was used to detect DNA double strand breaks, anti-phospho-histone H3-PE served as a mitotic cell marker, and anti-p53-FITC labeled an N-terminal domain of p53 and represented a DNA damage response biomarker. Also included in the working solution were RNase and propidium iodide to provide cell cycle and polyploidization information, and counting beads to calculate absolute nuclei counts (Sphero TM Multi-Fluorophore Particles, cat. no. FP-3057-2; Spherotech, Lake Forest, IL).
Two biomarkers, gH2AX and p53, were assessed based on median fluorescence intensity, and for all graphical representation and statistical analyses they were expressed as fold-change relative to a plate-specific solvent control arithmetic mean value. Gating logic required these events to exhibit propidium iodide-associated fluorescence corresponding to 2n -4n DNA content. To limit the influence that mitotic and apoptotic cells might have on these measurements, phospho-histone H3 (p-H3) positive cells and highly fluorescent gH2AX-positive events were excluded from analysis [Rogakou et al., 2000; McManus and Hendzel, 2005; Huang et al., 2006] . Region positions and gating logic are described in greater detail in Supporting Information file 1. p-H3 and polyploidy biomarkers were assessed based on their frequency among other cells. The p-H3 measurements were the proportion of p-H3-positive events that exhibited propidium iodide-associated fluorescence of 4n and greater DNA content relative to the number of total events with 2n and greater DNA content. Polyploidy was quantified as the proportion of 8n-positive events relative to the number of total events with 2n and greater DNA content. For all graphical representations and statistical analyses presented herein, the p-H3 and polyploidy data were converted to fold-change relative to a plate-specific solvent control arithmetic mean value.
Fluorescent latex microspheres were included in the working dye/ antibody solution at a known concentration and this allowed these particles to serve as counting beads. Nuclei to counting bead ratios were calculated for each sample, and this was used to determine absolute nuclei counts (those with 2n and greater DNA-associated propidium iodide fluorescence). These values were used to calculate 24 hr cytotoxicity values relative to plate-specific mean solvent control wells, and were expressed as %cytotoxicity, that is 100 -relative nuclei count at 24 hr.
Flow Cytometric Analysis
At 4 and 24 hr time points cells were resuspended with pipetting and then 25 mL were removed from each well and added to a new 96-well plate containing 50 mL/well of prealiquoted working MultiFlow Kit reagent. Mixing occurred by pipetting the contents of each well several times. After at least a 30 min room temperature incubation period, flow cytometric analysis occurred using either a Environmental and Molecular Mutagenesis. DOI 10.1002/em [2016] . Generally speaking, across the sites, 4 hr samples provided 1000 or more 2n and greater nuclei for analysis, and 24 hr samples provided 4000 or more 2n and greater nuclei.
Data Analysis: Global Evaluation Factors (GEF)
The Mouse Lymphoma Assay uses a GEF to signify when a biologically significant increase in mutant phenotype cell frequency occurs [Moore et al., 2006] . This value was based on the distribution of the negative control mutation frequency data from several proficient laboratories. In analogy to this, we evaluated whether chemical MoA determinations could be accomplished by comparing MultiFlow assay responses to biomarker-and time point-specific GEFs. To generate GEFs, aggregate fold-increase response data for each chemical studied across seven laboratories were pooled and applied to a partition platform (JMP v12.0.1, SAS Institute, Cary, NC). The chemicals were coded according to the a priori MoA information indicated in Table I , and for each biomarker and time point under consideration, the partition platform's decision tree calculated the split value that best parses the chemicals into their respective genotoxic MoA groups. Additional details about cutoff value calculations are provided as Supporting Information file 2. The resulting GEFs, shown below, are expressed as fold-increase over concurrent solvent controls.
GEFs for the three clastogen-responsive biormarkers 4 hr gH2AX, 4 hr p53, and 24 hr gH2AX, were 1.51-, 1.40-, and 2.11-fold, respectively; GEFs for the three aneugen-responsive biomarkers 4 hr p-H3, 24 hr p-H3, and 24 hr polyploidy, were 1.71-, 1.52-, and 5.86-fold, respectively; and The GEF for the pan-genotoxicant (clastogen-and aneugen-responsive) biomarker, 24 hr p53, was 1.45-fold.
Meeting or exceeding these interlaboratory-derived values identified a significant biomarker response at a particular time point. Note that as previously described , assay data were restricted to those concentrations that exhibited 20% relative nuclei counts at 24 hr. In general, the greatest differentiation of genotoxic MoA was evident with increasing chemical exposure. To normalize the responses across the diverse set of chemicals studied, and to give results stemming from higher exposures greater significance in these analyses, the partition platform's weight function was used, specifically the variable %cytotoxicity at 24 hr.
Comparisons of individual chemical and laboratory response data to GEFs were facilitated by a conditionally-formatted Excel file (Microsoft Corp., Redmond, WA), available as Supporting Information file 3. To synthesize the results of these multiple comparisons and to make judgments about genotoxic MoA, the following rules were applied:
A clastogen call required two successive concentrations to meet or exceed the GEF for at least two out of four clastogen-sensitive biomarkers (4 hr gH2AX, 4 hr p53, 24 hr gH2AX, and 24 hr p53); an aneugen call required two successive concentrations to meet or exceed the GEF for at least two out of four aneugen-sensitive biomarkers (4 hr p-H3, 24 hr p-H3, 24 hr polyploidy, and 24 hr p53); in cases where both clastogen-and aneugen-sensitive biomarkers exceeded GEF(s), the category with the greater number of significant biomarkers was selected as the predominant MoA; and when less than two clastogen-and two aneugen-sensitive biomarkers met or exceed the GEFs, the call was nongenotoxic under the test conditions used.
Data Analysis: Multinomial Logistic Regression
In addition to GEFs, we also evaluated a second strategy for assessing whether a genotoxic response occurred. A 4-factor multinomial logistic regression model that predicts predominant genotoxic MoA based on MultiFlow response data has been previously described . The approach used herein is a variant, an ensemble of two 4-factor multinomial logistic regression models that we believe has certain advantages for detecting genotoxicants that exhibit atypical response profiles. As with the previous logistic regression model, all chemicals were assigned an a priori genotoxic MoA classification, and fold-change values at non-precipitating concentrations with 20% relative nuclei counts at 24 hr were evaluated in JMP software's logistic regression modeling platform (v12.0.1). Using a forward-stepping approach, a clastogen-detection model was developed based on the fold-change data obtained for the following clastogen-sensitive biomarkers: 4 hr gH2AX, 4 hr p53, 24 hr gH2AX, and 24 hr p53. The resulting algorithm provides probability scores for a clastogenic MoA at every concentration evaluated. The same strategy was used to construct an aneugen-detection model, and this was based on the fold-change data obtained for the four following aneugen-sensitive biomarkers: 4 hr p-H3, 24 hr p-H3, 24 hr polyploidy, and 24 hr p53. The resulting algorithm provides probability scores for an aneugenic MoA at every concentration evaluated. Note that these models were only constructed for the two laboratories that studied a sufficient number of chemicals to support logistic regression model building, Litron and Orion, and were created on a laboratoryspecific basis. As described above for the partition platform, a weight function was used using the variable %cytotoxicity at 24 hr. The full algorithms are available upon request.
The logistic regression output was synthesized into a final call regarding predominant MoA by considering both the clastogen-and aneugendetection models' probability scores as follows: a clastogen call required two successive concentrations to exhibit clastogen probability scores 80%, or one concentration to exhibit one clastogen probability score 90%; an aneugen call required two successive concentrations to exhibit aneugen probability scores 80%, or one concentration to exhibit one aneugen probability score 90%; and a nongenotoxic call was defined as the absence of two successive concentrations exhibiting clastogen or aneugen probability scores 80%, and no one concentration exhibiting a clastogen or aneugen probability score 90%.
Definitions
Sensitivity and specificity values were used to assess the degree to which assay-derived MoA calls agreed with a priori designations. Therefore, sensitivity is the percentage of clastogens and aneugens whose MoA call agreed with the a priori designation and specificity is the percentage of non-genotoxicants identified as such. Overall concordance, relative to a priori MoA designations, is the percentage of clastogens, aneugens, and nongenotoxicants predicted as such. A second concordance value was determined, one based on the subset of chemicals that were studied at more than one laboratory (n 5 60 chemicals; referred to herein as concordance 60 ).
RESULTS AND DISCUSSION
Pilot Studies
Collaborators were introduced to kit reagents and flow cytometric analyses with pilot experiments that initially considered untreated cells and culminated with exposures to a prototypical clastogen and aneugen over a limited number of concentrations. These experiments served to ensure that adequate technical proficiency and Environmental and Molecular Mutagenesis. DOI 10.1002/em instrumentation considerations were in place before larger scale experimentation was initiated. This pilot work was conducted successfully without major issues. One noteworthy early finding was that not every flow cytometer model was capable of sufficiently resuspending nuclei and counting beads. This was readily evident from lower acquired nuclei and bead counts as sampling progressed through the plate. In general, syringe-type mixing was very effective, whereas orbital shaker-type mixers were not. In the latter case, operators were instructed to manually mix wells with multichannel pipettors immediately prior to each row being analyzed (i.e., every 12 samples). This was considerably less than ideal relative to the walkaway data collection capability that instruments with effective mixing were able to provide.
Collaborators readily achieved adequate antibody labeling, and after a longer incubation time was instituted (at least 30 min instead of 10), better stability of propidium iodide-associated fluorescence was achieved. The six groups' earliest experiments with several prototypical clastogens and aneugens demonstrated expected responses to each of the biomarkers. At this point, collaborators were invited to proceed to definitive experiments whereby chemicals listed in Table I were studied over a large range of concentrations (i.e., 20). Table I indicates the specific chemicals that were studied at each laboratory. Initial, qualitative impressions of the data suggested that each of the four key biomarkers were responding as expected. One way this was assessed was by graphing the collaborators' aggregate data against concentration (log10, mM). Figure 1 shows several biomarker responses for all chemicals and all concentrations, biomarkers that were observed to be sensitive to clastogens (4 hr gH2AX), aneugens (p-H3 and polyploidy), or both (24 hr p53). This view demonstrates that across laboratories the magnitude of effects increased with increasing exposure and there were obvious differences in the way the biomarkers were responding to clastogens versus aneugens. As reported by Bryce et al. [2016] , such signatures should be useful for predicting predominant MoA.
Interlaboratory Transferability
Individual laboratory data are graphed for one clastogen and one aneugen that were studied across several sites. Figure 2 (upper panel) shows responses to ethyl methanesulfonate, a relatively weak clastogen that nonethe-less produced consistent results across laboratories. The ethyl methanesulfonate data are instructive, as they show prototypical clastogen signatures: concentrationrelated increases in 4 hr gH2AX, some reduction to mitotic cells (p-H3 positive) at 4 hr, increases in p53 at 24 hr, and little to no polyploidy induction. Figure 2 (lower panel) shows responses to noscapine, an aneugen that also showed relatively consistent response profiles across sites. Noscapine is representative of a prototypical aneugenic signature: nil to slight increases in 4 hr gH2AX, marked elevation of p-H3 at 4 hr, increases in p53 at 24 hr, and elevated polyploidy. This example is also useful because it highlights an important aspect of the aneugenic signature. As shown in Figure 2 , two laboratories observed marked increases in polyploidy ( 18-fold), whereas two laboratories did not. We do not currently have an explanation for this finding, but it may be related to the fact that for some chemicals polyploidization occurs over a relatively narrow range of concentrations. In any event, as a practical matter, when considering signatures of aneugenicity it would appear to be useful to think of polyploidy as supportive of aneugenic MoA, and unwise to consider it a required feature.
Global Evaluation Factors
As described above, it was clear that collaborating laboratories observed response profiles that were generally similar to those previously reported by the reference laboratory. It was therefore of interest to evaluate whether the aggregate interlaboratory data could be used to derive GEFs for each endpoint and facilitate predominant genotoxic MoA predictions. The summary data each of 231 experiments are presented in Figure 3 , and the complete data set is available as a conditionally formatted spreadsheet (Supporting Information file 3).
As shown in Figure 3 , the MultiFlow assay in conjunction with GEFs was effective at detecting the reference aneugens, with 37/37 experiments yielding the correct call. Of the 194 experiments with clastogens and nongenotoxicants, only the presumed nongenotoxicant phenformin HCl was characterized as being aneugenic in 1 of 3 experiments (it might be described as an indeterminate MoA call given the equal number of aneugen and clastogen responses).
Of 90 experiments with clastogens, 80 were correctly predicted as clastogenic MoA. As shown in Figure 3 , half of the false negative results were from experiments with two chemicals, menadione and azidothymidine. In the latter case, it is conceivable that use of an alternate treatment/harvest schedule may have provided more robust responses [Kirsch-Volders et al., 2011] . Of 127 experiments with aneugens and nongenotoxicants, only three agents were misclassified as clastogenic, and all were presumed non-genotoxicants: imatinib mesylate (1 of 4 experiments), lovastatin (1 of 4 experiments), and phenformin HCl (indeterminate MoA in 1 of 3 experiments).
Using the GEFs approach, aggregate interlaboratory assay sensitivity and specificity values were 117/127 or 92.1% and 100/104 or 96.2%, respectively. Overall concordance with a priori MoA designations was 217/231 or 93.9%. Restricting the analysis to the subset of 60 chemicals that were studied at more than one laboratory Environmental and Molecular Mutagenesis. DOI 10.1002/em Fig. 1 . Fold-increase responses for four biomarkers are graphed against chemical concentration (log10). The graphs are aggregate data for 231 experiments conducted by seven laboratories. The data are coded according to genotoxic MoA: clastogens 5 red circles, aneugens 5 blue squares, and nongenotoxicants 5 green triangles. These graphs support the fact that these biomarkers as transferable across sites, and suggest that different response profiles among chemical classes should be valuable for elucidating genotoxic MoA.
Environmental and Molecular Mutagenesis. DOI 10.1002/em produced a similarly high value (concordance 60 5 196/207 or 94.7%). These performance metrics suggest GEFs generated across several laboratories represent one effective strategy for identifying when clastogen-as well as aneugen-sensitive biomarker responses are significantly induced.
While these performance metrics indicate the GEFs approach provides a good balance between sensitivity and specificity, there may be certain placements and roles for the assay that place a premium on maximizing sensitivity. One strategy for improving sensitivity may be to use laboratory-specific cutoff values as opposed to GEFs generated from data generated at multiple laboratories. This approach was studied by calculating cutoff values based solely on data from one laboratory (Litron). As shown by Figure 3 , the GEFs approach resulted in 28/33 successful clastogen experiments conducted at Litron (azathioprine, azidothymidine, emodin, menadione, and stavudine were misidentified as nongenotoxic). When Litron-specific cutoff values are applied to Litron data, 2 of the 5 false negatives noted above became correctly identified as clastogenic (emodin and stavudine), with no change to assay specificity. This analysis suggests modest gains to sensitivity may be realized with this strategy.
Multinomial Logistic Regression
In addition to global-and laboratory-specific evaluation factors, we also evaluated multinomial logistic regression's ability to detect clastogenic, aneugenic, and nongenotoxicant response profiles. This strategy was investigated for the two laboratories that studied enough chemicals to support construction of such models. Figure  4a shows aneugen predictions for each of 84 experiments performed at Litron. All 13 reference aneugens were correctly predicted as exhibiting a predominant aneugenic MoA. Of 71 experiments with clastogens and nongenotoxicants, none were misclassified as aneugenic. Figure 4b shows clastogen predictions for each of 84 experiments performed at Litron. Of 33 experiments with clastogens, 32 were correctly predicted as clastogenic MoA. The false negative result was for azathioprine. Of 51 experiments with aneugens and nongenotoxicants, only imatinib mesylate was mischaracterized as being clastogenic. Figure 5a shows aneugen predictions for each of 40 experiments performed at Orion. All five aneugens were correctly predicted as exhibiting a predominant aneugenic MoA. Of 35 experiments with clastogens and nongenotoxicants, none were misclassified as aneugens. Figure 5b shows clastogen predictions based on the data generated at Orion. All 14 experiments with clastogens resulted in the correct MoA call. Of 26 experiments with aneugens and non-genotoxicants, dexamethasone was mischaracterized as being clastogenic, and griseofulvin showed one elevated clastogenic probability score in addition to the several high aneugen probability scores that were observed in the aneugen-detection model.
Pooling Litron and Orion results, we find that assay sensitivity and specificity values were 64/65 or 98.5% and 57/59 or 96.6%, respectively. Even if we consider the mixed MoA result for griseofulvin as an incorrect call, overall concordance with a priori MoA designations was 120/124 or 96.6%. These performance metrics suggest multinomial logistic regression represents another effective strategy for elucidating genotoxicants' predominant MoA.
Advice to Novice Laboratories
Considering the transferability of the MultiFlow methodology and companion data analysis strategies described herein, new groups may be interested in evaluating this technology. Reflecting on our collective experiences, several pieces of advice are provided. Initially, one valuable exercise is to collect negative control data over several weeks of experimentation and consider the variability occurring for each biomarker and time point. To facilitate comparisons to a reference laboratory, Litron's aggregate solvent control data are available upon request. In terms of positive controls, we recommend beginning with reference chemicals from Table I , agents with relatively well known MoA that have been studied at multiple laboratories. Biomarker response profiles described here and elsewhere should be observed before initiating more extensive testing or beginning work with uncharacterized compounds, especially if they represent new chemical space.
Another piece of advice regards the manner by which the multiplexed data are analyzed and interpreted. Based on these studies, it would seem reasonable to begin by using the GEFs reported herein. Over time, as more chemicals and new chemical spaces are studied, these GEFs may need to be reconsidered. Whether current or even updated GEF values will be applicable to all chemical space(s) or whether they need to be tailored for some use cases is something that will require more research. Finally, whereas laboratory-specific cutoff values appeared to modestly increase assay sensitivity relative to GEFs, we speculate that there are likely more powerful ways to accomplish this, for example, using chemical training sets and machine learning approach(es).
In support of this view, an analysis strategy based on multinomial logistic regression was shown to work effectively with MultiFlow data. In this case, laboratoryspecific models were built that provided clastogen and aneugen probability scores that are readily applicable to making MoA predictions. Whereas GEFs or even laboratory-specific cutoff values are static, the logistic regression methodology considers the data more holistically. For instance with this approach modest foldchanges across several clastogen-sensitive responses would tend to synergize and can provide a high clastogen probability score even for weak clastogens that are not recognized by evaluating individual biomarker responses relative to GEFs. This is exemplified by Litron's experience with menadione. Whereas GEFs or even lab-specific cutoff values failed to detect menadione genotoxicity, the logistic regression algorithms interpreted several moderate biomarker responses as a clear indication of clastogenicity (>90% probability; see Fig. 6 ). Although machine learning approaches such as this hold much promise, it may be difficult for some groups to institute them, depending on biostatistical support and other considerations. It is also worth pointing out that there are alternatives to logistic regression that would likely be useful for predicting predominant genotoxic MoA. It is beyond the scope of this report to describe the multitude of machine learning approaches that we expect would be effective. In support of the suggestion that alternate prediction tools would likely have utility, one of the collaborating laboratories used a Random Forest technique to generate a high performing MoA prediction model. 
CONCLUSIONS
An efficient, add-and-read, multiplexed genotoxicity assay based on gH2AX, p-H3, p53, and polyploidization biomarkers was observed to be transferable across laboratories. Cutoff values, generated from individual or multiple laboratories' data, and multinomial logistic regression, were all found to be effective at synthesizing the results into predictions of predominant genotoxic MoA.
Future work will be needed to extend these promising results to the evaluation of additional chemical spaces and molecular mechanisms of action. In parallel with the benchtop laboratory work, it will be important to revisit the performance of the data analysis strategies presented herein. Logistic regression and other analysis strategies should also be studied for their ability to detect chemicals with mixed modes of genotoxic action, as well as their ability to include other data streams, when available, that contribute to MoA predictions. Finally, it should be acknowledged that while the current work focused on assay transferability and MoA determinations, it would be highly desirable to evaluate approaches for using these same biomarker response data to more thoroughly evaluate dose-response relationships and genotoxic potency.
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